. What’s the impetus for that pullback? So he can focus on his healthcare company, Mark Cuban Cost Plus Drugs, which currently offers steep discounts on over 350 different generic medications. The company can offer low prices by bypassing many of the pharmaceutical industry’s middlemen and buying directly from factories. Cuban has so far invested over $100 million in the business and is willing to spend more.
“If we get this right, this will be the most impactful thing I’ve ever done,” he says.Timothy Springer is still active in the lab, and published a paper on integrins earlier in September.The award, which he shares with two others, is for a set of discoveries in the 1970s that form the basis for new drug treatments today. Other awards were granted for Johns Hopkins Covid dashboard and non-invasive genetic screening.
No one is concerned with covid anymore. Moving on......